Skip To Main Content
Laura Kreutzer on Muck Rack

Laura Kreutzer

Verified
Acton
As seen in: Dow Jones and Company, Techfluential by Deloitte, The Wall Street Journal, MSN, WSJ Pro Venture Capital, The Wall Street Journal (China), MarketWatch, Mint, Fox Business, Morningstar, Dow Jones Newswires, MarketScreener, Financial News and
Editor/reporter at Dow Jones covering all things private equity. Former Sunday Columnist for WSJ. Proud working parent. Satire aficionado. Recovering optimist.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Laura

Contact Laura, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

European Firm Main Capital Partners Banks About $6 Billion for Software Deals

|
By Laura Kreutzer Verified
| WSJ Pro Venture Capital Verified
The firm reached the upper limits for two new funds despite investor concern about potential AI disruptions of the software sector Main Capital Partners’ headquarters in The Hague. Photo: Main Capital Partners European software investor Main Capital Partners rounded up €5.25 billion, or about $6 billion, for its two newest funds, effectively doubling its total assets at a time of mounting investor concern about the software sector.
Open in Who Shared Issue with article?

Blackstone's Redemption Wave | Lender Sues Law Firm Pillsbury Winthrop

|
By Laura Kreutzer Verified
| createsend.com
Happy Friday! As we head into the weekend, private credit has once again dominated private markets headlines and not in a particularly uplifting way. This morning’s top stories all relate to challenges and disputes in the private credit world. Our Journal colleagues report on continued redemption requests from investors in private credit interval funds and semi-liquid business development companies, including Blackstone’s massive Bcred fund.
Open in Who Shared Issue with article?

Thermo Fisher to sell microbiology business to Astorg

|
By Laura Kreutzer Verified, Colin Kellaher Verified
| MSN Verified
Thermo Fisher Scientific has struck a deal to sell its microbiology business to European private-equity firm Astorg for about $1.075 billion. Thermo Fisher on Monday said the microbiology business, which provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food-safety testing, generated $645 million in revenue last year. Waltham, Mass., life-sciences giant Thermo Fisher posted 2025 revenue of nearly $44.6 billion.
Open in Who Shared View Duplicates (2) Issue with article?
See all 606 licensed articles (628 Total)